Abstract
Background: ACC/AHA guidelines support the use of the P2Y(12) inhibitors clopidogrel, prasugrel, or ticagrelor in acute myocardial infarction (AMI). L......
小提示:本篇文献需要登录阅读全文,点击跳转登录